Disaster medicine and public health preparedness · 2025
Impact of the 2018 Western Japan Heavy Rain Disaster on Anti-influenza Virus Drug Prescribing: A Longitudinal Analysis Using the National Health Insurance Claims Database.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Utsumi Shu, Yoshida Shuhei, Ohshimo Shinichiro, Shime Nobuaki, Matsumoto Masatoshi
Аннотация
OBJECTIVES: No study has evaluated the relationship between heavy rain disasters and influenza by comparing victims and non-victims, and we investigated the association between the 2018 western Japan heavy rain disaster and influenza.
METHODS: All patients registered in the National Health Insurance Claims Database and treated in the Hiroshima, Okayama, and Ehime prefectures were included in this retrospective cohort study conducted 1-year post-disaster. A multivariate mixed-effects logistic regression analysis was used to assess the association between the disaster and anti-influenza drug prescribing. A difference-in-differences analysis was conducted to assess anti-influenza drug use for the 4-month period immediately before and every 4 months for a year post-disaster.
RESULTS: This study included 6 176 300 individuals (victims: 36 076 [0.60%]); 2573 (7.1%) and 458 157 (7.4%) in the victim and non-victim groups, respectively, used anti-influenza drugs in the year following the flood. The victims were significantly more likely than non-victims to use anti-influenza drug (risk ratio 1.18; 95% confidence interval [CI] 1.12-1.42). The victims used significantly more anti-influenza drugs in the 4 months immediately post-disaster compared with just before the disaster (odds ratio 3.62; 95% CI 1.77-7.41).
CONCLUSIONS: Anti-influenza drug use was higher among victims of the 2018 Western Japan heavy rain disaster than among non-victims.
METHODS: All patients registered in the National Health Insurance Claims Database and treated in the Hiroshima, Okayama, and Ehime prefectures were included in this retrospective cohort study conducted 1-year post-disaster. A multivariate mixed-effects logistic regression analysis was used to assess the association between the disaster and anti-influenza drug prescribing. A difference-in-differences analysis was conducted to assess anti-influenza drug use for the 4-month period immediately before and every 4 months for a year post-disaster.
RESULTS: This study included 6 176 300 individuals (victims: 36 076 [0.60%]); 2573 (7.1%) and 458 157 (7.4%) in the victim and non-victim groups, respectively, used anti-influenza drugs in the year following the flood. The victims were significantly more likely than non-victims to use anti-influenza drug (risk ratio 1.18; 95% confidence interval [CI] 1.12-1.42). The victims used significantly more anti-influenza drugs in the 4 months immediately post-disaster compared with just before the disaster (odds ratio 3.62; 95% CI 1.77-7.41).
CONCLUSIONS: Anti-influenza drug use was higher among victims of the 2018 Western Japan heavy rain disaster than among non-victims.